Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study.
Arie Jan VerschoorSaskia LitièreSandrine MarréaudIan R JudsonMaud ToulmondeEva WardelmannAxel LeCesneAndré B P van KuilenburgPublished in: Clinical sarcoma research (2020)
This large retrospective study is the first to report progression free survival and overall survival after completion of 6 cycles of first line doxorubicin containing chemotherapy. These results are important when designing new studies exploring for example maintenance therapy after doxorubicin based chemotherapy.
Keyphrases
- free survival
- end stage renal disease
- drug delivery
- newly diagnosed
- ejection fraction
- locally advanced
- chronic kidney disease
- cancer therapy
- peritoneal dialysis
- prognostic factors
- emergency department
- squamous cell carcinoma
- mesenchymal stem cells
- stem cells
- patient reported outcomes
- rectal cancer
- combination therapy
- replacement therapy
- cell therapy
- drug induced